In the large SUSTAIN and PIONEER trials, only about 2060% of the CRP reduction was explained by weight and glycaemia
Atkins MB, Lotze MT, Dutcher JP, Fisher RI, Weiss G, Margolin K et al
At TrimRx, we understand that the transition to a medical weight loss program involves more than just a prescription
Unlike semaglutide, which targets GLP-1 only, or tirzepatide (GLP-1 + GIP), Retatrutide adds glucagon receptor activity that increases resting energy expenditure, a mechanism not present in either predecessor
Here are some ways to stay connected: Schedule Regular Checkups : Regular appointments with your doctor can help monitor your overall health while on semaglutide and Zofran